Anthracycline and concurrent radiotherapy as adjuvant treatment of operable breast cancer: A retrospective cohort study in a single institution

BMC Research Notes

Volumn 3, Issue , 2010, Pages

  Ismaili, Nabil ^a,b   Elmajjaoui, Sanaa ^a   Lalya, Issam ^a   Boulaamane, Lamia ^a   Belbaraka, Rhizlane ^a   Abahssain, Halima ^a   Aassab, Rachi ^a   Benjaafar, Noureddine ^a   El Guddari, Brahim El Khalil ^a   El Mesbahi, Omar ^c   Sbitti, Yassir ^d   Ismaili, Mohammed ^e   Errihani, Hassan ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Morocco)

^b Regional Cancer Center   (Morocco)

^c HASSAN II UNIVERSITY HOSPITAL   (Morocco)

^d MILITARY HOSPITAL MOHAMMED V   (Morocco)

^e MOULAY ISMAIL UNIVERSITY   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77958124045     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-3-247     Document Type: Article

References (40)

1. Defining the role of post-mastectomy radiotherapy: The new evidence. LJ Pierce AS Lichter, Oncology (Williston Park) 1996 10 991 1002 8837118
2. Postmastectomy radiotherapy: Then and now. B Fowble, Oncology (Williston Park) 1997 11 213 239 9057176
3. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. M Overgaard PS Hansen J Overgaard C Rose M Andersson F Bach M Kjaer CC Gadeberg HT Mouridsen MB Jensen K Zedeler, N Engl J Med 1997 337 949 955 10.1056/NEJM199710023371401 9395428
4. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. M Overgaard MB Jensen J Overgaard PS Hansen C Rose M Andersson C Kamby M Kjaer CC Gadeberg BB Rasmussen M Blichert-Toft HT Mouridsen, Lancet 1999 353 1641 1648 10.1016/S0140-6736(98)09201-0 10335782
5. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Ragaz I Olivotto JJ Spinelli N Phillips SM Jackson KS Wilson MA Knowling CM Coppin L Weir K Gelmon N Le R Durand AJ Coldman M Manji, J Natl Cancer Inst 2005 97 116 126 10.1093/jnci/djh297 15657341 (Pubitemid 40277091)
6. Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group, N Engl J Med 1995 333 1444 1455 10.1056/NEJM199511303332202 7477144
7. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group, Lancet 2000 355 1757 1770 10.1016/S0140-6736(00)02263-7 10832826
8. Radiotherapy after breast-conserving surgery in small breast carcinoma: Longterm results of a randomized trial. U Veronesi E Marubini L Mariani V Galimberti A Luini P Veronesi B Salvadori R Zucali, Ann Oncol 2001 12 997 1003 10.1023/A:1011136326943 11521809
9. Twenty-years follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. B Fisher S Anderson J Bryant RG Margolese M Deutsch ER Fisher JH Jeong N Wolmark, N Engl J Med 2002 347 1233 1241 10.1056/NEJMoa022152 12393820
10. Phenylalanine mustard (L-PAM) in the management of primary breast cancer: a report of early findings. B Fisher P Carbone SG Economou R Frelick A Glass H Lerner C Redmond M Zelen P Band DL Katrych N Wolmark ER Fisher, N Engl J Med 1975 292 117 122 10.1056/NEJM197501162920301 1105174
11. Combination chemotherapy as an adjuvant treatment in operable breast cancer. G Bonadonna E Brusamolino P Valagussa A Rossi L Brugnatelli C Brambilla M De Lena G Tancini E Bajetta R Musumeci U Veronesi, N Engl J Med 1976 294 405 410 10.1056/NEJM197602192940801 1246307
12. Systemic treatment of early breast cancer by hormonal cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths along 75,000 women. Early Breast Cancer Trialists' Collaborative Group, Lancet 1992 339 1 15 1345950
13. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. A Recht SE Come IC Henderson RS Gelman B Silver DF Hayes LN Shulman JR Harris, N Engl J Med 1996 334 1356 1361 10.1056/NEJM199605233342102 8614420 (Pubitemid 26152714)
14. Does delay in breast irradiation following conservative breast surgery in nodenegative cancer patients have an impact on risk of recurrence? O Vujovic F Perera AR Dar L Stitt E Yu SM Voruganti PT Truong, Int J Radiat Oncol Biol Phys 1998 40 869 874 9531372
15. Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. TA Buchholz KK Hunt CM Amosson SL Tucker EA Strom MD McNeese AU Buzdar SE Singletary GN Hortobagyi, Cancer J Sci Am 1999 5 159 164 10367172
16. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control? CE Leonard ME Wood B Zhen J Rankin DA Waitz L Norton K Howell S Sedlacek, J Clin Oncol 1995 13 2906 2915 8523054
17. Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. WF Hartsell DC Recine KL Griem AK Murthy, Cancer 1995 76 2497 2503 10.1002/1097-0142(19951215)76:12<2497::AID-CNCR2820761214>3.0.CO;2-6 8625076
18. Effect of delay in radiation in the combined modality treatment of breast cancer. TA Buchholz MM Austin-Seymour RE Moe GK Ellis RB Livingston JG Pelton TW Griffin, Int J Radiat Oncol Biol Phys 1993 26 23 35 8482628
19. Integration of conservative surgery, radiotherapy and chemotherapy for the treatment of early-stage, node-positive breast cancer: Sequencing, timing, and outcome. A Recht SE Come RS Gelman M Goldstein S Tishler SM Gore AL Abner FA Vicini B Silver JL Connolly, J Clin Oncol 1991 9 1662 1667 1875223
20. Why and how to combine chemotherapy and radiation therapy in breast cancer patients. AK Dubey A Recht S Come L Shulman J Harris, Recent Results Cancer Res 1998 152 247 254 9928562
21. Concurrent CMF and radiation therapy for early stage breast cancer: Results of a pilot study. A Dubey A Recht SE Come RS Gelman B Silver JR Harris LN Shulman, Int J Radiat Oncol Biol Phys 1999 45 877 884 10571193
22. Concurrent sequencing of full-dose CMF chemotherapy and radiation therapy in early breast cancer has no effect on treatment delivery. C Faul A Brufsky K Gerszten J Flickinger A Kunschner H Jacob V Vogel, Eur J Cancer 2003 39 763 768 10.1016/S0959-8049(02)00834-1 12651201
23. Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: A phase I/II trial. SC Formenti M Volm KA Skinner D Spicer D Cohen E Perez AC Bettini S Groshen C Gee B Florentine M Press P Danenberg F Muggia, J Clin Oncol 2003 21 864 870 10.1200/JCO.2003.06.132 12610186
24. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Lancet 2005 20;365 9472 1687 717
25. Enhanced toxicity of radiotherapy due to epirubicin containing adjuvant chemotherapy in breast carcinoma patients. W Hoogenraad J Franssen J van Turnhout, Radiother Oncol 1992 24 42 (abstr 158)
26. Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients: A prospective, comparative, non-randomised study. WE Fiets RP van Helvoirt JW Nortier I van der Tweel H Struikmans, Eur J Cancer 2003 39 1081 1088 10.1016/S0959-8049(03)00178-3 12736107
27. Systolic and diastolic cardiac dysfunction early after the initiation of doxorubicin therapy: Significance of gender and concurrent mediastinal radiation. IP Clements BJ Davis GA Wiseman, Nucl Med Commun 2002 23 521 527 10.1097/00006231-200206000-00003 12029206
28. Concurrent chemoradiotherapy in adjuvant treatment of breast cancer. N Ismaili N Mellas O Masbah S Elmajjaoui S Arifi I Bekkouch S Ahid Z Bazid MA Tazi A Erraki O El Mesbahi N Benjaafar K El Gueddari Bel M Ismaili S Afqir H Errihani, Radiat Oncol 2009 4 12 10.1186/1748-717X-4-12 19351405
29. Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer. RC Zellars V Stearns D Frassica F Asrari T Tsangaris L Myers S DiPasquale JR Lange LK Jacobs LA Emens DK Armstrong JH Fetting E Garrett-Mayer NE Davidson AC Wolff, J Clin Oncol 2009 27 2816 22 10.1200/JCO.2008.20.0139 19332718
30. Anthracycline and concurrent radiotherapy significantly reduced loco-regional breast cancer relapse rate [abstract]. N Ismaili H Errihani, EJC supplements 2010 8 72
31. AJCC cancer staging manual. FL Greene DL Page ID Fleming, New York: Springer-Verglag 6 2002
32. Nonparametric estimation from incomplete observations. EL Kaplan P Meier, J Am Stat Assoc 1958 53 457 481 10.2307/2281868
33. Regression models and life-tables. DR Cox, J R Stat Soc B 1972 34 187 202
34. Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer: a phase I/II trial. VE Kouloulias CE Dardoufas JR Kouvaris CS Gennatas AK Polyzos HJ Gogas PH Sandilos NK Uzunoglu EG Malas LJ Vlahos, Clin Cancer Res 2002 8 374 82 11839652
35. Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials. J Kao SD Conzen NT Jaskowiak DH Song W Recant R Singh GA Masters GF Fleming R Heimann, Int J Radiat Oncol Biol Phys 2005 61 4 1045 53 15752883
36. Reirradiation of recurrent breast cancer with and without concurrent chemotherapy. F Würschmidt J Dahle C Petersen C Wenzel M Kretschmer C Bastian, Radiat Oncol 2008 3 28 10.1186/1748-717X-3-28 18801165
37. Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer. PL Bedard A Di Leo MJ Piccart-Gebhart, Nat Rev Clin Oncol 2010 7 1 22 36 10.1038/nrclinonc.2009.186 19997076
38. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: Final results of the ARCOSEIN trial. A Toledano D Azria P Garaud A Fourquet D Serin JF Bosset J Miny-Buffet A Favre O Le Floch G Calais, J Clin Oncol 2007 25 405 10 10.1200/JCO.2006.07.8576 17264336
39. A phase III randomized study on the sequence of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer. G Arcangeli P Pinnaro R Rambone D Giannarelli M Benassi, Int J Radiat Oncol Biol Phys 2006 64 161 167 16226397
40. A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: Final results. J Rouessé B De la Lande F Bertheault-Cvitkovic D Serin Y Grac M Combe B Leduc V Lucas L Demange TD Nguyen D Castèra C Krzisch R Villet E Mouret-Fourme JR Garbay C Noguès Centre René Huguenin Breast Cancer Group, Int J Radiat Oncol Biol Phys 2006 64 1072 1080 16504757